by PEAK Medicals | 4 October 2024
Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Talks Related To Metastatic NSCLC AstraZeneca & Daiichi-Sankyo Best Practices in Managing Adverse Events...
by PEAK Medicals | 3 October 2024
Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Talks Related To Resectable NSCLC MSD Symposium Insights into the treatment of resectable, non-targetable...
by PEAK Medicals | 12 May 2024
Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Industry Symposia AstraZeneca & Daiichi-Sankyo Best Practices in Managing Adverse Events with ADCs in...